Cempra Inc CEMP:NASDAQ (Common Stock)

LastChange / % ChangeDividend YieldVolumeAvg Volume (10 day)
12.61 -0.05   -0.39% 405,022525.5K
Market data is delayed by at least 20 minutes.
Summary chart showing the current equity's performance of over the past 1 days
  • Advanced Charts
  • Embed the above chart in your blog or website

    Customize, copy, and then paste the generated code into your website.

Previous close 10/8/2014

Latest News Headlines for Cempra Inc

No News for Cempra Inc

Latest Annual and Quarterly SEC Filings

More Filings
10-K

This report contains detailed information about the company's business finances and management.

10-Q

Quarterly reports contain financial statement, a discussion from management and a list of company events (stock splits, acquisitions, etc.)

Company Background

Cempra, Inc., formerly Cempra Holdings, LLC, is a development-stage and clinical-stage pharmaceutical company focused on developing antibiotics to meet medical needs in the treatment of bacterial infectious diseases, particularly respiratory tract infections and chronic and acute staphylococcal infections. Its program CEM-101 is developing in both oral and intravenous (IV), formulations initially for the treatment of community-acquired bacterial pneumonia (CABP). Its second program is Taksta, which is developing in the United States as an oral treatment for bacterial infections caused by Staphylococcus aureus (S. Aureus), including methicillin-resistant S. aureus (MRSA). As of January 30, 2012, the Company completed a Phase II clinical trial in, which the oral formulation of CEM-101 demonstrated comparable efficacy to the levofloxacin. As of January 30, 2012, its second program Taksta has completed a Phase II clinical trial in patients.

http://www.cempra.com/

Loading...

collapse, right-facing arrow indicating collapsed view of sectionOverview

A table providing an overview of the stock
Bid | Size-- | --
Ask | Size-- | --
Price Open12.64
Previous Close12.61
Day High--
Day Low--
52 Week High1/22/2014 | 15.39
52 Week Low4/15/2014 | 8.10
% Off 52 Week High-18.06%
% Off 52 Week Low55.68%
Beta (5 Yr)--
Volatility Avg10/8/2014 | 51.14
10-Day Avg. Volume525,509
Market data is delayed by at least 20 minutes.

collapse, right-facing arrow indicating collapsed view of sectionFundamentals

A table providing the fundamentals of the stock
EPS (TTM)6/30/2014 | -1.92
P/E Ratio6/30/2014 | --
Market CapSmall Cap | 419M
Shares Outstanding33.24M
Float31.1M

collapse, right-facing arrow indicating collapsed view of sectionDividends

A table providing information about the dividends of the stock
Dividend Yield--
Ex-Date--
Dividend Announcement--
Date of Record--
Payable-- - --
Payable Date--

collapse, right-facing arrow indicating collapsed view of sectionShare Statistics

A table providing statistics about shares of the stock
Shares Short2.86M
Short Ratio23.4
Short % of Float9.18%
As of 9/15/2014

Peers Information HelpCEMP Cempra Inc vs. Peers

Peers 
CEMP
Cempra Inc
1.78%
Johnson & Johnson
14.54%
Pfizer Inc.
-4.08%
Abbott Laboratories
9.94%
Cubist Pharmaceuticals Inc
-5.05%
CEMP
Cempra Inc
0.00%
Johnson & Johnson
2.67%
Pfizer Inc.
3.54%
Abbott Laboratories
2.09%
Cubist Pharmaceuticals Inc
--
CEMP
Cempra Inc
-0.39%
Johnson & Johnson
2.46%
Pfizer Inc.
2.05%
Abbott Laboratories
1.64%
Cubist Pharmaceuticals Inc
2.33%
Compare these stocks